NasdaqGM - Delayed Quote USD

Aspire Biopharma Holdings, Inc. (ASBP)

0.3768
-0.0224
(-5.61%)
At close: June 10 at 4:00:01 PM EDT
0.3701
-0.01
(-1.78%)
After hours: June 10 at 7:58:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Cost of Revenue
--
--
0
0
Gross Profit
--
--
0
0
Operating Expense
18,414.1810
3,088.6710
1,340.1680
596.4910
Operating Income
-18,414.1810
-3,088.6710
-1,340.1680
-596.4910
Net Non Operating Interest Income Expense
-632.8790
-342.9480
5,804.2470
0
Other Income Expense
--
-9,105.8530
--
--
Pretax Income
-28,247.8300
-12,537.4720
4,464.0790
-596.4910
Tax Provision
--
--
0.4810
0.6260
Net Income Common Stockholders
-28,247.8300
-12,537.4720
4,464.0790
-597.1170
Diluted NI Available to Com Stockholders
-28,247.8300
-12,537.4720
4,464.0790
-597.1170
Basic EPS
-0.61
-0.27
0.10
-0.01
Diluted EPS
-0.61
-0.27
0.10
-0.01
Basic Average Shares
46,007.5130
46,007.5130
46,007.5130
46,007.5130
Diluted Average Shares
46,007.5130
46,007.5130
46,007.5130
46,007.5130
Total Expenses
18,414.1810
3,088.6710
1,340.1680
596.4910
Net Income from Continuing & Discontinued Operation
-28,247.8300
-12,537.4720
4,464.0790
-597.1170
Normalized Income
-28,152.9130
-12,537.4720
4,464.0790
-597.1170
Interest Income
--
548.6760
5,813.2130
--
Interest Expense
1,181.5550
891.6240
8.9660
0
Net Interest Income
-632.8790
-342.9480
5,804.2470
0
EBIT
-27,066.2750
-11,645.8480
4,473.0450
-596.4910
EBITDA
-27,066.2750
-11,645.8480
4,473.0450
-596.4910
Reconciled Cost of Revenue
--
--
0
0
Reconciled Depreciation
--
0
0
0
Net Income from Continuing Operation Net Minority Interest
-28,247.8300
-12,537.4720
4,464.0790
-597.1170
Total Unusual Items Excluding Goodwill
-94.9170
--
--
--
Total Unusual Items
-94.9170
--
--
--
Normalized EBITDA
-26,971.3580
-11,645.8480
4,473.0450
-596.4910
Tax Rate for Calcs
0
0
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 4/11/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PSTV Plus Therapeutics, Inc.
0.3499
+0.46%
 
OGEN Oragenics, Inc.
4.5100
+4.16%
 
IMNN Imunon, Inc.
1.6200
+21.80%
 
NLSP NLS Pharmaceutics AG
2.5500
-7.27%
 
TNFA TNF Pharmaceuticals, Inc.
0.1761
+4.20%
 
ABP Abpro Corporation
0.2730
+10.17%
 
SILO Silo Pharma, Inc.
0.5870
-5.54%
 
PLRZ Polyrizon Ltd.
0.8090
-3.39%
 
ALZN Alzamend Neuro, Inc.
3.3200
-3.77%
 
TRAW Traws Pharma, Inc.
1.8600
+12.05%